RATIONALE: The Severe Asthma Research Program cohort includes subjects with persistent asthma who have undergone detailed phenotypic characterization. Previous univariate methods compared features of mild, moderate, and severe asthma. OBJECTIVES: To identify novel asthma phenotypes using an unsupervised hierarchical cluster analysis. METHODS: Reduction of the initial 628 variables to 34 core variables was achieved by elimination of redundant data and transformation of categorical variables into ranked ordinal composite variables. Cluster analysis was performed on 726 subjects. MEASUREMENTS AND MAIN RESULTS: Five groups were identified. Subjects in Cluster 1 (n = 110) have early onset atopic asthma with normal lung function treated with two or fewer controller medications (82%) and minimal health care utilization. Cluster 2 (n = 321) consists of subjects with early-onset atopic asthma and preserved lung function but increased medication requirements (29% on three or more medications) and health care utilization. Cluster 3 (n = 59) is a unique group of mostly older obese women with late-onset nonatopic asthma, moderate reductions in FEV(1), and frequent oral corticosteroid use to manage exacerbations. Subjects in Clusters 4 (n = 120) and 5 (n = 116) have severe airflow obstruction with bronchodilator responsiveness but differ in to their ability to attain normal lung function, age of asthma onset, atopic status, and use of oral corticosteroids. CONCLUSIONS: Five distinct clinical phenotypes of asthma have been identified using unsupervised hierarchical cluster analysis. All clusters contain subjects who meet the American Thoracic Society definition of severe asthma, which supports clinical heterogeneity in asthma and the need for new approaches for the classification of disease severity in asthma.
RATIONALE: The Severe Asthma Research Program cohort includes subjects with persistent asthma who have undergone detailed phenotypic characterization. Previous univariate methods compared features of mild, moderate, and severe asthma. OBJECTIVES: To identify novel asthma phenotypes using an unsupervised hierarchical cluster analysis. METHODS: Reduction of the initial 628 variables to 34 core variables was achieved by elimination of redundant data and transformation of categorical variables into ranked ordinal composite variables. Cluster analysis was performed on 726 subjects. MEASUREMENTS AND MAIN RESULTS: Five groups were identified. Subjects in Cluster 1 (n = 110) have early onset atopic asthma with normal lung function treated with two or fewer controller medications (82%) and minimal health care utilization. Cluster 2 (n = 321) consists of subjects with early-onset atopic asthma and preserved lung function but increased medication requirements (29% on three or more medications) and health care utilization. Cluster 3 (n = 59) is a unique group of mostly older obesewomen with late-onset nonatopic asthma, moderate reductions in FEV(1), and frequent oral corticosteroid use to manage exacerbations. Subjects in Clusters 4 (n = 120) and 5 (n = 116) have severe airflow obstruction with bronchodilator responsiveness but differ in to their ability to attain normal lung function, age of asthma onset, atopic status, and use of oral corticosteroids. CONCLUSIONS: Five distinct clinical phenotypes of asthma have been identified using unsupervised hierarchical cluster analysis. All clusters contain subjects who meet the American Thoracic Society definition of severe asthma, which supports clinical heterogeneity in asthma and the need for new approaches for the classification of disease severity in asthma.
Authors: Wendy C Moore; Eugene R Bleecker; Douglas Curran-Everett; Serpil C Erzurum; Bill T Ameredes; Leonard Bacharier; William J Calhoun; Mario Castro; Kian Fan Chung; Melissa P Clark; Raed A Dweik; Anne M Fitzpatrick; Benjamin Gaston; Mark Hew; Iftikhar Hussain; Nizar N Jarjour; Elliot Israel; Bruce D Levy; James R Murphy; Stephen P Peters; W Gerald Teague; Deborah A Meyers; William W Busse; Sally E Wenzel Journal: J Allergy Clin Immunol Date: 2007-02 Impact factor: 10.793
Authors: Sally E Wenzel; Silvana Balzar; Elizabeth Ampleford; Gregory A Hawkins; William W Busse; William J Calhoun; Mario Castro; K Fan Chung; Serpil Erzurum; Benjamin Gaston; Elliot Israel; W Gerald Teague; Douglas Curran-Everett; Deborah A Meyers; Eugene R Bleecker Journal: Am J Respir Crit Care Med Date: 2006-12-14 Impact factor: 21.405
Authors: Mary K Miller; Charles Johnson; Dave P Miller; Yamo Deniz; Eugene R Bleecker; Sally E Wenzel Journal: J Allergy Clin Immunol Date: 2005-10-03 Impact factor: 10.793
Authors: Suzy A A Comhair; Kristin S Ricci; Mercedes Arroliga; Abigail R Lara; Raed A Dweik; Wei Song; Stanley L Hazen; Eugene R Bleecker; William W Busse; Kian Fan Chung; Benjamin Gaston; Annette Hastie; Mark Hew; Nizar Jarjour; Wendy Moore; Stephen Peters; W Gerald Teague; Sally E Wenzel; Serpil C Erzurum Journal: Am J Respir Crit Care Med Date: 2005-05-05 Impact factor: 21.405
Authors: Anne M Fitzpatrick; Benjamin M Gaston; Serpil C Erzurum; W Gerald Teague Journal: J Allergy Clin Immunol Date: 2006-10-10 Impact factor: 10.793
Authors: Peter M A Calverley; Julie A Anderson; Bartolome Celli; Gary T Ferguson; Christine Jenkins; Paul W Jones; Julie C Yates; Jørgen Vestbo Journal: N Engl J Med Date: 2007-02-22 Impact factor: 91.245
Authors: Dominick E Shaw; Mike A Berry; Mike Thomas; Ruth H Green; Chris E Brightling; Andrew J Wardlaw; Ian D Pavord Journal: Am J Respir Crit Care Med Date: 2007-05-11 Impact factor: 21.405
Authors: Mario Castro; Sean B Fain; Eric A Hoffman; David S Gierada; Serpil C Erzurum; Sally Wenzel Journal: J Allergy Clin Immunol Date: 2011-06-02 Impact factor: 10.793
Authors: Mats W Johansson; Shih-Tsung Han; Kristin A Gunderson; William W Busse; Nizar N Jarjour; Deane F Mosher Journal: Am J Respir Crit Care Med Date: 2012-01-06 Impact factor: 21.405
Authors: Akshay Sood; Hans Petersen; Christopher M Blanchette; Paula Meek; Maria A Picchi; Steven A Belinsky; Yohannes Tesfaigzi Journal: Chest Date: 2012-08 Impact factor: 9.410
Authors: Dara G Torgerson; Daniel Capurso; Rasika A Mathias; Penelope E Graves; Ryan D Hernandez; Terri H Beaty; Eugene R Bleecker; Benjamin A Raby; Deborah A Meyers; Kathleen C Barnes; Scott T Weiss; Fernando D Martinez; Dan L Nicolae; Carole Ober Journal: Am J Hum Genet Date: 2012-02-10 Impact factor: 11.025
Authors: Isabell Ricklefs; Ioanna Barkas; Melody G Duvall; Manuela Cernadas; Nicole L Grossman; Elliot Israel; Eugene R Bleecker; Mario Castro; Serpil C Erzurum; John V Fahy; Benjamin M Gaston; Loren C Denlinger; David T Mauger; Sally E Wenzel; Suzy A Comhair; Andrea M Coverstone; Merritt L Fajt; Annette T Hastie; Mats W Johansson; Michael C Peters; Brenda R Phillips; Bruce D Levy Journal: JCI Insight Date: 2017-07-20
Authors: Kathryn Blake; James D Cury; Jobayer Hossain; Kelan Tantisira; Jianwei Wang; Edward Mougey; John Lima Journal: Pulm Pharmacol Ther Date: 2013-02-04 Impact factor: 3.410
Authors: W Gerald Teague; Brenda R Phillips; John V Fahy; Sally E Wenzel; Anne M Fitzpatrick; Wendy C Moore; Annette T Hastie; Eugene R Bleecker; Deborah A Meyers; Stephen P Peters; Mario Castro; Andrea M Coverstone; Leonard B Bacharier; Ngoc P Ly; Michael C Peters; Loren C Denlinger; Sima Ramratnam; Ronald L Sorkness; Benjamin M Gaston; Serpil C Erzurum; Suzy A A Comhair; Ross E Myers; Joe Zein; Mark D DeBoer; Anne-Marie Irani; Elliot Israel; Bruce Levy; Juan Carlos Cardet; Wanda Phipatanakul; Jonathan M Gaffin; Fernando Holguin; Merritt L Fajt; Shean J Aujla; David T Mauger; Nizar N Jarjour Journal: J Allergy Clin Immunol Pract Date: 2017-08-31
Authors: Teal S Hallstrand; Ying Lai; William R Henderson; William A Altemeier; Michael H Gelb Journal: Pulm Pharmacol Ther Date: 2012-12 Impact factor: 3.410
Authors: Edward Zoratti; Suzanne Havstad; Ganesa Wegienka; Charlotte Nicholas; Kevin R Bobbitt; Kimberley J Woodcroft; Dennis R Ownby; Christine Cole Johnson Journal: Ann Allergy Asthma Immunol Date: 2014-05-05 Impact factor: 6.347